Artemis Medicare Services (BOM:542919) Cash Flow for Dividends: ₹0 Mil (TTM As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

BOM:542919 Artemis Medicare Services Ltd BOM:542919
89 GF Score
Price ₹269.70
GF Value ₹264.72
Valuation Fairly Valued
! 5 Warning Signs
View Full Analysis

What is Artemis Medicare Services Cash Flow for Dividends?

Artemis Medicare Services BOM:542919 -2.28% 89 Cash Flow for Dividends is ₹0 Mil as of Mar. 2026. GuruFocus rates BOM:542919 with a GF Score™ of 89/100 and a GF Value™ of ₹264.72 (Fairly Valued). The stock has 5 warning signs investors should review.

Artemis Medicare Services's cash flow for dividends for the three months ended in Mar. 2026 was ₹0 Mil. Its cash flow for dividends for the trailing twelve months (TTM) ended in Mar. 2026 was ₹0 Mil.

Note: A negative number here means the payment of dividends. When pays more dividends, the absolute value gets bigger.

Artemis Medicare Services's annual payment of dividends declined from Mar. 2024 (₹-61 Mil) to Mar. 2025 (₹-60 Mil) but then increased from Mar. 2025 (₹-60 Mil) to Mar. 2026 (₹-61 Mil).


Artemis Medicare Services Cash Flow for Dividends Related Terms


Artemis Medicare Services Cash Flow for Dividends Historical Data

* Premium members only.

The historical data trend for Artemis Medicare Services's Cash Flow for Dividends can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Artemis Medicare Services Cash Flow for Dividends Chart

Artemis Medicare Services Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Cash Flow for Dividends
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 -61.14 -59.76 -61.32

Artemis Medicare Services Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Cash Flow for Dividends Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
BOM:542919
89GF Score
Artemis Medicare Services Ltd BOM:542919
Cash Flow for Dividends is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Artemis Medicare Services Cash Flow for Dividends Calculation

Cash flow for dividends refers to the payment of cash to shareholders as dividends when the company generates income.

Cash Flow for Dividends for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

What does a Cash Flow for Dividends of ₹0 Mil mean?
Artemis Medicare Services (BOM:542919) has a Cash Flow for Dividends of ₹0 Mil as of Mar. 2026. Cash Flow for Dividends represent the amount a company pays as dividends for a specific accounting period. View historical data for Artemis Medicare Services and its competitors.
Is Artemis Medicare Services' Cash Flow for Dividends too high?
Artemis Medicare Services' current Cash Flow for Dividends is ₹0 Mil. Overall, Artemis Medicare Services has a GF Score™ of 89/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Artemis Medicare Services' Cash Flow for Dividends compare to HCA and THC?
Artemis Medicare Services' Cash Flow for Dividends of ₹0 Mil can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cash Flow for Dividends for a Healthcare Providers & Services company?
A good Cash Flow for Dividends depends on the Healthcare Providers & Services industry context. However, Cash Flow for Dividends should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cash Flow for Dividends mean?
A high Cash Flow for Dividends can signal that a stock is expensive relative to its fundamentals. Cash Flow for Dividends represent the amount a company pays as dividends for a specific accounting period. View historical data for Artemis Medicare Services and its competitors. Artemis Medicare Services's current Cash Flow for Dividends is ₹0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Artemis Medicare Services stock overvalued right now?
Based on GuruFocus' analysis, Artemis Medicare Services (BOM:542919) is currently considered Fairly Valued. The stock's GF Value™ is ₹264.72, compared to a current price of ₹269.70 — trading 1.9% above its estimated fair value. The current Cash Flow for Dividends is ₹0 Mil. Artemis Medicare Services' overall GF Score™ is 89/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cash Flow for Dividends calculated?
Cash Flow for Dividends is calculated from a company's financial statements. For Artemis Medicare Services (BOM:542919), the current Cash Flow for Dividends is ₹0 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Artemis Medicare Services (BOM:542919) Overvalued in 2026?

Based on GuruFocus' analysis, Artemis Medicare Services stock appears to be overvalued. The current stock price of ₹269.70 is trading 1.9% above its estimated GF Value™ of ₹264.72. GuruFocus considers Artemis Medicare Services to be Fairly Valued.

Key valuation signals for BOM:542919:

  • Cash Flow for Dividends: ₹0 Mil
  • GF Value™: ₹264.72 vs. price of ₹269.70 (1.9% above fair value)
  • GF Score™: 89/100 with 5 warning signs

No single metric tells the full story. See the BOM:542919 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Artemis Medicare Services Business Description

Address Artemis Hospital, Sector 51, Gurugram, HR, IND, 122001
Artemis Medicare Services Ltd is engaged in managing and operating multi-specialty hospitals. The hospital provides treatments for Allergy and Immunology, Blood (Haematology), Bones, Muscles and Joints (Orthopaedics), Brain, Spine and Nervous System, Cancer (Oncology), Circulatory (Vascular), Digestive (Gastroenterology), Endocrine, Diabetes And Metabolism, Dermatology, Heart (Cardiology), Infectious Diseases, Kidneys (Renal), Lung (Pulmonary), Mouth, Teeth And Face (Oral And Maxillofacial), Obstetrics And Gynecology, Psychiatry, Rheumatology (Arthritis And Joint Disease), Surgery, and Urology. The company derives revenue mainly from Healthcare Services through the operation of multi-specialty Hospitals.
89GF Score

Get the complete analysis for BOM:542919

Cash Flow for Dividends is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹269.70
Price
₹264.72
GF Value